Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112028834B reveals a safe 2-step route to 6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole with high purity and yield.
Novel low-temperature method for high-purity deuterated intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel scalable process for NUC-7738 anticancer prodrug. Enhanced diastereomer enrichment and cost-effective protecting group strategy for pharmaceutical manufacturing.
Novel Pd-Cu catalytic method for phenanthrene intermediates ensures high yield and scalable production for global pharmaceutical supply chains.
Novel Pd-Cu catalytic method for phenanthrene derivatives. Enhances yield and supply chain stability for pharmaceutical manufacturing.
Advanced Salen-catalyzed kinetic resolution process for high-purity statin intermediates. Delivers cost reduction in API manufacturing and reliable supply chain continuity.
Efficient copper-catalyzed synthesis of quaternary carbon center indolones. Mild conditions, high yield, scalable for pharmaceutical intermediates supply chain.
Patent CN118496071A details a novel one-pot method using heavy water and NHC catalysts for high-purity deuterated intermediates ensuring supply chain stability.
Discover a metal-free photocatalytic method for synthesizing high-purity amide compounds using nitriles and diarylmethanes, offering significant supply chain and cost advantages.
Novel boron-catalyzed hydroamination method offers high yield and mild conditions for pharmaceutical intermediates manufacturing ensuring supply chain reliability.
Novel patent CN117024485B details safe methylation route for 2'-OMe adenosine, offering cost reduction and scalability for pharmaceutical intermediate supply chains.
Novel chemical route enhances hypericin yield and scalability. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN105837525A reveals a mild copper-catalyzed route for antibacterial triazine intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114057642B reveals a mild, high-yield synthesis for Mivacurium intermediates, offering significant cost reduction and safety improvements for API manufacturing.
Novel synthetic route for EPZ-6438 offers high yield and mild conditions. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Novel patent CN104151271B details scalable cabazitaxel synthesis avoiding chromatography. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners.
Patent CN111187255B reveals a mild, high-purity synthesis route for D-ilaprazole. Discover cost-effective manufacturing and supply chain advantages for API intermediates.
Novel Pd-catalyzed one-pot synthesis for indenoacetates. High atom utilization, wide substrate scope. Reliable supply for pharma intermediates.
Patent CN109369353A details a palladium-catalyzed route for metoprolol intermediates offering significant cost reduction in pharma manufacturing and enhanced supply chain reliability for buyers.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.